Tumor Targeting Gene Vector for Visual Tracking of Bcl-2 siRNA Transfection and Anti-Tumor Therapy

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Nanotechnology

Background:

• Bcl-2 is an oncogene crucial in cancer development.
• Targeted gene therapy offers a promising approach for cancer treatment.
• Efficient delivery of small interfering RNA (siRNA) is essential for gene therapy efficacy.

Purpose of the Study:

• To develop a multifunctional gene vector (DPL) for targeted delivery of Bcl-2 siRNA.
• To evaluate DPL's capacity for tumor imaging and gene therapy both in vitro and in vivo.
• To compare DPL's performance with a commercial transfection reagent.

Main Methods:

• Synthesis of a diketopyrrolopyrrole (DPP)-derived vector (DPL) with fluorescent properties.
• Loading of Bcl-2 siRNA onto the DPL vector.
• In vitro and in vivo studies to assess gene transfer, tumor targeting, and therapeutic efficacy.
• Evaluation of Bcl-2 protein expression and tumor growth inhibition.

Main Results:

• DPL exhibited enhanced fluorescence upon siRNA interaction, enabling tracking of gene transfer.
• DPL demonstrated superior downregulation of Bcl-2 protein expression compared to Lipo 2000.
• DPL achieved significant antitumor efficacy with reduced amounts of Bcl-2 siRNA.
• In vivo studies confirmed DPL's tumor-targeting ability via the enhanced permeability and retention (EPR) effect.

Conclusions:

• The DPL vector is an effective tool for targeted Bcl-2 siRNA delivery and tumor imaging.
• DPL offers a promising platform for developing multifunctional gene vectors for cancer therapy.
• This study highlights the potential of DPP-based materials in advanced gene delivery systems.